The Gross Margin of Esperion Therapeutics Inc (ESPR) is 79.36%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 79.36% |
| 2023-12-31 | 62.81% |
| 2022-12-31 | 64.24% |
| 2021-12-31 | 81.89% |
| 2020-12-31 | 98.95% |